C2 Galactosylceramide (d18:1/2:0) (Synonyms: Galactosylceramide (d18:1/2:0), GalCer(d18:1/2:0), β-Gal-C2-Cer, N-acetyl Psychosine) |
| Catalog No.GC43064 |
C2 Galactosilceramida (d18:1/2:0) (C2 Galactosilceramida (d18:1/2:0)), α-C2-ceramida galactosilada, tiene actividad inmunoestimuladora.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 35823-61-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
C2 Galactosylceramide is a bioactive sphingolipid. It inhibits IL-4 production by 23.24% in EL4 T cells when used at a concentration of 10 μM. C2 Galactosylceramide stimulates NF-κB activity in C6 glioma cells and activates mast cells in a concentration-dependent manner. It is cytotoxic to U937 cells in vitro (IC50 = 33 μM). C2 Galactosylceramide also suppresses the allogeneic mixed leukocyte reaction (MLR) response in murine spleen cells in a concentration-dependent manner.
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *